Ablation of CaMKIIdelta oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Lebek S, Chemello F, Caravia XM, Tan W, et al. Science 2023;379:179-185.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lebek S, Chemello F, Caravia XM, Tan W, et al. Ablation of CaMKIIdelta oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Science 2023;379:179-185.
PMID: 36634166